Protease Inhibitor Vs. Raltegravir-based ART and Inflammation in HIV Infection
Clinical trial NCT02691065 · COMPLETED
Trial details
- NCT number
- NCT02691065
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-20
- Primary completion
- 2021-03-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.